Poultry Science,
Год журнала:
2022,
Номер
101(9), С. 102037 - 102037
Опубликована: Июль 1, 2022
The
diversity
of
bacteria
and
fungi
in
the
gut
microbiota
commercial
broilers
that
raised
cages
from
hatch
to
end
production
cycle
were
examined
by
an
analysis
3,592
3,899
amplicon
sequence
variants
(ASVs),
respectively.
More
than
90%
sequences
bacterial
communities
related
Firmicutes
Proteobacteria.
fungal
Ascomycota,
Basidiomycota,
Glomeromycota.
A
statistical
composition
succession
showed
age
was
one
main
factors
affecting
intestinal
microbial
broilers.
increasingly
complex
community
transient
occurred
along
with
increase
age.
This
dynamic
change
observed
be
similar
between
fungi.
had
a
special
structure
first
3
d
after
birth
broiler.
quite
stable
period
rapid
skeletal
growth
(d
14–21),
then
changed
significantly
gaining
weight
35–42),
thus
indicating
unique
structures
at
different
developmental
stages.
We
several
occupied
key
functions
broilers,
suggesting
homeostasis
might
affected
losses
via
altering
interactions
microbiota.
study
aimed
provide
data
basis
for
manipulating
stages,
order
improve
health
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Окт. 9, 2023
Abstract
Individual
variability
in
drug
response
(IVDR)
can
be
a
major
cause
of
adverse
reactions
(ADRs)
and
prolonged
therapy,
resulting
substantial
health
economic
burden.
Despite
extensive
research
pharmacogenomics
regarding
the
impact
individual
genetic
background
on
pharmacokinetics
(PK)
pharmacodynamics
(PD),
diversity
explains
only
limited
proportion
IVDR.
The
role
gut
microbiota,
also
known
as
second
genome,
its
metabolites
modulating
therapeutic
outcomes
human
diseases
have
been
highlighted
by
recent
studies.
Consequently,
burgeoning
field
pharmacomicrobiomics
aims
to
explore
correlation
between
microbiota
variation
IVDR
or
ADRs.
This
review
presents
an
up-to-date
overview
intricate
interactions
classical
agents
for
systemic
diseases,
including
cancer,
cardiovascular
(CVDs),
endocrine
others.
We
summarise
how
directly
indirectly,
modify
absorption,
distribution,
metabolism,
excretion
(ADME)
drugs.
Conversely,
drugs
modulate
composition
function
leading
changes
microbial
metabolism
immune
response.
discuss
practical
challenges,
strategies,
opportunities
this
field,
emphasizing
critical
need
develop
innovative
approach
multi-omics,
integrate
various
data
types,
genomic
data,
well
translate
lab
into
clinical
practice.
To
sum
up,
represents
promising
avenue
address
improve
patient
outcomes,
further
is
imperative
unlock
full
potential
precision
medicine.
Abstract
Background
Remodeling
eubiosis
of
the
gut
microenvironment
may
contribute
to
preventing
occurrence
and
development
depression.
Mounting
experimental
evidence
has
shown
that
complement
C3
signaling
is
associated
with
pathogenesis
depression,
disruption
microbiota
be
an
underlying
cause
system
activation.
However,
mechanism
by
which
participates
in
gut-brain
crosstalk
depression
remains
unknown.
Results
In
present
study,
we
found
chronic
unpredictable
mild
stress
(CUMS)-induced
mice
exhibited
obvious
depression-like
behavior
as
well
cognitive
impairment,
was
significant
dysbiosis,
especially
enrichment
Proteobacteria
elevation
microbiota-derived
lipopolysaccharides
(LPS).
addition,
peripheral
central
activation
C3/CR3-mediated
aberrant
synaptic
pruning
microglia
have
also
been
observed.
Transplantation
from
CUMS-induced
model
into
specific
pathogen-free
germ-free
induced
concomitant
impairment
recipient
mice,
accompanied
increased
C3/CR3
pathway
prefrontal
cortex
abnormalities
microglia-mediated
pruning.
Conversely,
antidepressants
fecal
transplantation
antidepressant-treated
donors
improved
behaviors
restored
microbiome
disturbances
depressed
mice.
Concurrently,
inhibition
pathway,
amelioration
abnormal
pruning,
expression
synapsin
postsynaptic
density
protein
95
were
Collectively,
our
results
revealed
dysbiosis
induces
through
synapse
C3,
key
targeting
microbes
treat
Conclusions
Our
findings
provide
novel
insights
involvement
chemotactic
The
polymorphic
microbiome
is
considered
a
new
hallmark
of
cancer.
Advances
in
High-Throughput
Sequencing
have
fostered
rapid
developments
research.
interaction
between
cancer
cells,
immune
and
microbiota
defined
as
the
immuno-oncology
(IOM)
axis.
Fungal
microbes
(the
mycobiome),
although
representing
only
∼
0.1-1%
microbiome,
are
critical
immunologically
active
component
tumor
microbiome.
Accumulating
evidence
suggests
possible
involvement
commensal
pathogenic
fungi
initiation,
progression,
treatment
responsiveness.
tumor-associated
mycobiome
mainly
consists
gut
mycobiome,
oral
intratumoral
mycobiome.
However,
role
remains
poorly
understood,
diversity
complexity
analytical
methods
make
it
challenging
to
access
this
field.
This
review
aims
elucidate
causal
complicit
roles
development
progression
while
highlighting
issues
that
need
be
addressed
executing
such
We
systematically
summarize
advantages
limitations
current
fungal
detection
analysis
methods.
enumerate
integrate
these
recent
findings
into
our
understanding
accompanied
by
prospect
novel
exhilarating
clinical
implications.
Frontiers in Microbiology,
Год журнала:
2022,
Номер
13
Опубликована: Авг. 12, 2022
The
coronavirus
disease
2019
(COVID-19)
is
an
infectious
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
According
to
the
World
Health
Organization
statistics,
more
than
500
million
individuals
have
been
infected
and
6
deaths
resulted
worldwide.
Although
COVID-19
mainly
affects
system,
considerable
evidence
shows
that
digestive,
cardiovascular,
nervous,
reproductive
systems
can
all
be
involved.
Angiotensin-converting
enzyme
(AEC2),
target
of
SARS-CoV-2
invasion
host
distributed
in
gastrointestinal
tract.
Studies
found
microbiota
contributes
onset
progression
many
diseases,
including
COVID-19.
Here,
we
firstly
conclude
characterization
respiratory,
gut,
oral
microbial
dysbiosis,
bacteria,
fungi,
viruses.
Then
explore
potential
mechanisms
involvement
Microbial
dysbiosis
could
influence
complex
interactions
with
immunity.
Moreover,
may
impact
on
through
their
metabolites
or
modulation
ACE2
expression.
Subsequently,
generalize
as
diagnostic
markers
for
patients
its
possible
association
post-acute
(PACS)
relapse
after
recovery.
Finally,
proposed
directed
microbiota-targeted
treatments
from
perspective
gut
microecology
such
probiotics
prebiotics,
fecal
transplantation
antibiotics,
other
interventions
traditional
Chinese
medicine,
vaccines,
ACE2-based
treatments.
Gut,
Год журнала:
2023,
Номер
72(7), С. 1410 - 1425
Опубликована: Май 5, 2023
The
microbiome
may
impact
cancer
development,
progression
and
treatment
responsiveness,
but
its
fungal
components
remain
insufficiently
studied
in
this
context.
In
review,
we
highlight
accumulating
evidence
suggesting
a
possible
involvement
of
commensal
pathogenic
fungi
modulation
cancer-related
processes.
We
discuss
the
mechanisms
by
which
can
influence
tumour
biology,
locally
activity
exerted
within
microenvironment,
or
remotely
through
secretion
bioactive
metabolites,
host
immunity
communications
with
neighbouring
bacterial
commensals.
examine
prospects
utilising
fungi-related
molecular
signatures
diagnosis,
patient
stratification
assessment
while
highlighting
challenges
limitations
faced
performing
such
research.
all,
demonstrate
that
likely
constitute
important
members
mucosal
tumour-residing
microbiomes.
Exploration
inter-kingdom
interactions
decoding
their
causal
impacts
on
biology
enable
harnessing
into
diagnosis
treatment.
Recent
studies
revealed
a
significant
role
of
the
gut
fungal
community
in
human
health.
Here,
we
investigated
content
and
variation
mycobiota
among
subjects
from
European
population.
We
explored
interplay
between
fungi
various
host-related
sociodemographic,
lifestyle,
health,
dietary
factors.
The
study
included
923
participants.
Fecal
DNA
samples
were
analyzed
by
whole-metagenome
high-throughput
sequencing.
Subsequently,
taxonomic
profiles
determined
accompanied
computational
statistical
analyses
association
with
53
Fungal
communities
characterized
high
prevalence
Saccharomyces,
Candida,
Sporisorium.
Ten
factors
found
to
correlate
significantly
overall
variation.
Most
diet
related,
including
consumption
chips,
meat,
sodas,
sweetening,
processed
food,
alcohol,
followed
age
marital
status.
Differences
α-
and/or
β-diversity
also
reported
for
other
such
as
body
mass
index
(BMI),
job
type,
autoimmunological
diseases,
probiotics.
Differential
abundance
analysis
species
that
exhibited
different
patterns
changes
under
specific
conditions.
is
dominated
yeast,
Malassezia,
Candida.
Although
intervolunteer
variability
was
high,
several
persisted
across
most
samples,
which
may
be
evidence
core
exists.
Moreover,
showed
diet,
age,
status
influence
mycobiota.
To
our
knowledge,
this
first
large
comprehensive
cohort
terms
associations
an
extensive
differentiated
set
IMPORTANCE
inhabited
many
organisms,
bacteria
fungi,
affect
However,
research
on
mycobiome
still
rare.
European-based
missing.
Our
results
beer,
alcohol
consumption,
associated
abundances
at
level
can
suggest
potentially
valuable
paths
further,
narrowly
focused
its
impact
In
coming
era
microbiome-based
precision
medicine,
further
into
relationship
mycobial
structures
result
new
preventive
approaches
or
therapeutic
procedures.
A
diverse
array
of
commensal
microorganisms
inhabits
the
human
intestinal
tract.
The
most
abundant
and
studied
members
this
microbial
community
are
undoubtedly
bacteria.
Their
important
role
in
gut
physiology,
defense
against
pathogens,
immune
system
education
has
been
well
documented
over
last
decades.
However,
microbiome
is
not
restricted
to
It
encompasses
entire
breadth
life:
viruses,
archaea,
fungi,
protists,
parasitic
worms
can
also
be
found
gut.
While
less
than
bacteria,
their
divergent
but
roles
during
health
disease
have
become
increasingly
more
appreciated.
This
review
focuses
on
these
understudied
microbiome.
We
will
detail
composition
development
communities
specifically
highlight
functional
interactions
with
enteric
such
as
species
family